Manish Hathiramani of Deen Dayal Investments told CNBC-TV18, "Biocon is a sell with a target of Rs 400 and stoploss of Rs 435. There was a brief correction on this stock and the stock again clot back and attempted its resistance level of about Rs 440. It has reacted negatively over there. We see a gradual u-turn in it and it is again headed down. I feel it is showing weakness on most other technical parameters as well."
At 15:00 hrs Biocon was quoting at Rs 417, up Rs 3.80, or 0.92 percent on the BSE.
The share touched its 52-week high Rs 553.70 and 52-week low Rs 411.75 on 04 July, 2014 and 24 December, 2014, respectively.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!